Working… Menu

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01174121
Recruitment Status : Suspended
First Posted : August 3, 2010
Last Update Posted : May 25, 2021
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 29, 2023
Estimated Study Completion Date : December 27, 2024
Publications automatically indexed to this study by Identifier (NCT Number):